EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 383 filers reported holding EXELIXIS INC in Q1 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $20,000 | -20.0% | 1,100 | 0.0% | 0.01% | -21.4% |
Q1 2021 | $25,000 | +13.6% | 1,100 | 0.0% | 0.01% | +7.7% |
Q4 2020 | $22,000 | -18.5% | 1,100 | 0.0% | 0.01% | -23.5% |
Q3 2020 | $27,000 | +3.8% | 1,100 | 0.0% | 0.02% | 0.0% |
Q2 2020 | $26,000 | +85.7% | 1,100 | +37.5% | 0.02% | +54.5% |
Q1 2020 | $14,000 | 0.0% | 800 | 0.0% | 0.01% | +22.2% |
Q4 2019 | $14,000 | +27.3% | 800 | +33.3% | 0.01% | +28.6% |
Q3 2019 | $11,000 | -42.1% | 600 | -33.3% | 0.01% | -46.2% |
Q2 2019 | $19,000 | -9.5% | 900 | 0.0% | 0.01% | -13.3% |
Q1 2019 | $21,000 | -8.7% | 900 | -30.8% | 0.02% | -6.2% |
Q3 2018 | $23,000 | -17.9% | 1,300 | 0.0% | 0.02% | -23.8% |
Q2 2018 | $28,000 | -3.4% | 1,300 | 0.0% | 0.02% | +5.0% |
Q1 2018 | $29,000 | -75.2% | 1,300 | -66.2% | 0.02% | -73.7% |
Q4 2017 | $117,000 | -2.5% | 3,850 | -22.2% | 0.08% | -6.2% |
Q3 2017 | $120,000 | – | 4,950 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,001,073 | $320,572,000 | 64.48% |
Sargent Investment Group, LLC | 432,125 | $9,235,000 | 4.22% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 443,534 | $9,483,000 | 3.52% |
Bellevue Group AG | 3,878,800 | $82,890,000 | 1.42% |
CAPITAL MANAGEMENT CORP /VA | 237,855 | $5,083,000 | 1.40% |
Orbimed Advisors | 3,912,900 | $83,619,000 | 1.30% |
Portolan Capital Management | 540,590 | $11,552,000 | 1.24% |
TEALWOOD ASSET MANAGEMENT INC | 139,347 | $2,978,000 | 1.21% |
Signition LP | 84,120 | $1,798,000,000 | 1.18% |
Penn Capital Management Company, LLC | 529,630 | $11,318,000 | 1.12% |